Kolexia
Mir Olivier Oncologie médicale
Mir Olivier
Oncologie médicale
Amgen Sas
Neuilly-sur-Seine, France
491 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Tumeurs stromales gastro-intestinales Tumeurs du sein Récidive tumorale locale Tumeurs des tissus mous Carcinomes Métastase tumorale Hypertension artérielle Tumeurs osseuses

Collaborateurs

Voir plus
Le Cesne Axel
Le Cesne Axel
Gustave-Roussy, Villejuif, France
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France
Italiano Antoine
Italiano Antoine
Institut Bergonié, Bordeaux, France
Goldwasser Francois
Goldwasser Francois
Hôpital Cochin, Paris, France

Industries

Voir plus
Edimark
8 collaboration(s)
Dernière en 2022
B3TSI
6 collaboration(s)
Dernière en 2023
TBWA\ADELPHI
3 collaboration(s)
Dernière en 2021
AEC PARTNERS SAS
2 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma: A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Essai Clinique (Epizyme, Inc.)   29 février 2024
Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma: A Phase 1b/3 Global, Randomized, Double-blind, Placebo-Controlled Trial of Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma
Essai Clinique (Epizyme, Inc.)   27 février 2024
Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation: A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Essai Clinique (Servier)   09 février 2024
36 Evaluation of transplacental transfer of cancer therapies in melanoma via the perfused human placental model
SMFM 44th Annual Meeting: The Pregnancy Meeting   01 janvier 2024
119 Transplacental transfer of alectinib and osimertinib using an ex vivo human placental perfusion model
SMFM 44th Annual Meeting: The Pregnancy Meeting   01 janvier 2024
Image-guided core biopsy for pelvic lesions of unknown origin.
The British journal of surgery   07 novembre 2023
REGOBONE: A Randomized Phase II, Placebo-controlled, Multicenter Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
Essai Clinique (Unicancer)   06 novembre 2023
Cancer-associated Thrombosis: EVE & API-CAT - Prof. Robert McBane and Prof. Isabelle Mahé
Youtube @ MARKUS at HOMe   01 novembre 2023
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma: A Phase 2 Study of XL184 (Cabozantinib) in Treating Patients With Relapsed Osteosarcomas and Ewing Sarcomas
Essai Clinique (National Cancer Institute)   28 octobre 2023
Intraoperative motive for incomplete resection in primary retroperitoneal sarcoma.
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie   17 octobre 2023